AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ATOSSA THERAPEUTICS, INC. Director's Dealing 2023

Nov 15, 2023

Director's Dealing

Opens in your device viewer

Issuer: ATOSSA THERAPEUTICS, INC. (ATOS)
CIK: 0001488039
Period of Report: 2023-11-15

Reporting Person: Finn Jonathan (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-15	Stock Option (right to buy)	$0.65	A	62500	Acquired	2033-11-15	Common Stock (62500)	Direct

F1: The options shall vest in four equal quarterly installments following November 15, 2023.